文献速递泌尿生殖腹部MR

PI-RADS 2.1版评分系统在检测移行区前列腺癌方面优于2版:一项诊断研究

PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study.
PubMed 文献 · Abdom Radiol (NY) · 2020-09-09

本研究回顾性再分析2016年3月1日至2018年10月31日就诊于苏州大学附属第二医院泌尿外科并接受MRI检查的前列腺疾病患者影像,按PI-RADS 2.1版重新评分并与2版比较。结果显示2.1版对读者1敏感度更高(85% vs 79%,P=0.03)但特异度更低(65% vs 83%,P<0.001)、AUC更低(0.749 vs 0.809,P<0.001);读者2两次判读中2.1版特异度均更低,第二次判读敏感度更高(88% vs 78%,P<0.001)。结论提示2.1版可能提高移行区前列腺癌检出,但因特异度降低可能导致更多活检。

要点

  • PI-RADS 2.1版对移行区前列腺癌的敏感度高于2版,但特异度和AUC更低。
  • 读者2两次判读间的一致性kappa为0.321。
  • 2.1版可能因特异度降低而导致更多活检。

诊断标准与关键数值

  • 读者1:PI-RADS 2.1版 vs 2版,敏感度85% vs 79%(P=0.03),特异度65% vs 83%(P<0.001),AUC 0.749 vs 0.809(P<0.001)。
  • 读者2第一次判读:PI-RADS 2.1版 vs 2版,特异度67% vs 91%(P<0.001),AUC 0.702 vs 0.844(P<0.001)。
  • 读者2第二次判读:PI-RADS 2.1版 vs 2版,敏感度88% vs 78%(P<0.001),特异度77% vs 91%(P<0.001)。
  • 读者2两次判读间的一致性kappa为0.321。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The studies comparing the versions 2 vs. 2.1 of the Prostate Imaging Reporting and Data System (PI-RADS) are rare. This study aimed to evaluate whether PI-RADS version 2.1 is superior in detecting transition zone prostate cancer in comparison with PI-RADS version 2.

METHODS: This was a diagnostic study of patients with prostate diseases who visited the Urology Department of The Second Affiliated Hospital of Soochow University and underwent a magnetic resonance imaging (MRI) examination between 03-01-2016 and 10-31-2018. The images originally analyzed using PI-RADS version 2 were retrospectively re-analyzed and scored in 2019 according to the updated PI-RADS version 2.1. The kappa and receiver operating characteristic (ROC) curves were used.

RESULTS: For Reader 1, compared with PI-RADS version 2, version 2.1 had higher sensitivity (85% vs. 79%, P = 0.03), lower specificity (65% vs. 83%, P < 0.001), and lower area under the curve (AUC) (0.749 vs. 0.809, P < 0.001). For Reader 2 (first attempt), compared with PI-RADS version 2, version 2.1 had lower specificity (67% vs. 91%, P < 0.001) and lower AUC (0.702 vs. 0.844, P < 0.001). For Reader 2 (second attempt), compared with PI-RADS version 2, version 2.1 had higher sensitivity (88% vs. 78%, P < 0.001) and lower specificity (77% vs. 91%, P < 0.001). The kappa between the two attempts for Reader 2 was 0.321.

CONCLUSION: These results suggest that PI-RADS version 2.1 might improve the detection of prostate cancers in the transition zone compared with PI-RADS version 2 but that it might results in higher numbers of biopsies because of lower specificity.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wang Z, Zhao W, Shen J, et al. PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study. Abdom Radiol (NY). 2020. PMID: 32902659. doi:10.1007/s00261-020-02724-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。